Your browser doesn't support javascript.
loading
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.
Hammam, Nevin; Tharwat, Samar; Shereef, Rawhya R El; Elsaman, Ahmed M; Khalil, Noha M; Fathi, Hanan M; Salem, Mohamed N; El-Saadany, Hanan M; Samy, Nermeen; El-Bahnasawy, Amany S; Abdel-Fattah, Yousra H; Amer, Marwa A; ElShebini, Emad; El-Shanawany, Amira T; El-Hammady, Dina H; Noor, Rasha Abdel; ElKhalifa, Marwa; Ismail, Faten; Fawzy, Rasha M; El-Najjar, Amany R; Selim, Zahraa I; Abaza, Nouran M; Radwan, Ahmed R; Elazeem, Mervat IAbd; Mohsen, Wael Abdel; Moshrif, Abdel Hafeez; Mohamed, Eman F; Aglan, Loay I; Senara, Soha; Ibrahim, Maha E; Khalifa, Iman; Owaidy, Rasha El; Fakharany, Noha El; Mohammed, Reem Hamdy A; Gheita, Tamer A.
Afiliación
  • Hammam N; Rheumatology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Tharwat S; Rheumatology Department, University of California San Francisco (UCSF), San Francisco, CA, USA.
  • Shereef RRE; Rheumatology Unit, Internal Medicine, Mansoura University, Dakahlia, Egypt.
  • Elsaman AM; Rheumatology Department, Faculty of Medicine, Minia University, Minia, Egypt.
  • Khalil NM; Rheumatology Department, Faculty of Medicine, Sohag University, Sohag, Egypt.
  • Fathi HM; Internal Medicine Department, Rheumatology Unit, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Salem MN; Rheumatology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
  • El-Saadany HM; Internal Medicine Department, Rheumatology Unit, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
  • Samy N; Rheumatology Department, Faculty of Medicine, Tanta University, Gharbia, Egypt.
  • El-Bahnasawy AS; Internal Medicine Department, Rheumatology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Abdel-Fattah YH; Rheumatology Department, Faculty of Medicine, Mansoura University, Dakahlia, Egypt.
  • Amer MA; Rheumatology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • ElShebini E; Rheumatology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • El-Shanawany AT; Internal Medicine Department, Rheumatology Unit, Menoufia University, Menoufia, Egypt.
  • El-Hammady DH; Rheumatology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt.
  • Noor RA; Rheumatology Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
  • ElKhalifa M; Internal Medicine Department, Rheumatology Unit, Tanta University, Gharbia, Egypt.
  • Ismail F; Internal Medicine Department, Rheumatology Unit, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Fawzy RM; Rheumatology Department, Faculty of Medicine, Minia University, Minia, Egypt.
  • El-Najjar AR; Rheumatology Department, Faculty of Medicine, Benha University, Kalubia, Egypt.
  • Selim ZI; Rheumatology Department, Faculty of Medicine, Zagazig University, Sharkia, Egypt.
  • Abaza NM; Rheumatology Department, University of California San Francisco (UCSF), San Francisco, CA, USA.
  • Radwan AR; Rheumatology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Elazeem MI; Rheumatology Department, Faculty of Medicine, Sohag University, Sohag, Egypt.
  • Mohsen WA; Rheumatology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
  • Moshrif AH; Rheumatology Department, Faculty of Medicine, South Valley University, Qena, Egypt.
  • Mohamed EF; Rheumatology Department, Faculty of Medicine, Al-Azhar University, Assiut, Egypt.
  • Aglan LI; Internal Medicine Department, Rheumatology Unit, Faculty of Medicine (Girls), Al-Azhar University, Cairo, Egypt.
  • Senara S; Rheumatology Department, Faculty of Medicine, Aswan University, Aswan, Egypt.
  • Ibrahim ME; Rheumatology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
  • Khalifa I; Rheumatology Department, Faculty of Medicine, Suez-Canal University, Ismailia, Egypt.
  • Owaidy RE; Pediatrics Department, Rheumatology and Nephrology Unit, Helwan University, Cairo, Egypt.
  • Fakharany NE; Pediatrics Department, Rheumatology Unit, Ain Shams University, Cairo, Egypt.
  • Mohammed RHA; Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Gheita TA; Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Rheumatol Int ; 41(9): 1607-1616, 2021 09.
Article en En | MEDLINE | ID: mdl-34244818
ABSTRACT

OBJECTIVES:

The aim of the present work was to explore the perspectives of Egyptian Rheumatology staff members as regards the coronavirus disease-19 (COVID-19) vaccine.

METHODS:

The survey is composed of 25 questions. Some questions were adapted from the global rheumatology alliance COVID-19 survey for patients.

RESULTS:

187 rheumatology staff members across Egypt from 18 universities and authorizations actively participated with a valid response. The mean time needed to complete the survey was 17.7 ± 13 min. Participants were 159 (85%) females (FM 5.71). One-third agreed that they will be vaccinated once available, 24.6% have already received at least one dose, 29.4% are unsure while 16% will not take it. Furthermore, 70.1% agreed that they will recommend it to the rheumatic diseases (RD) patients once available, 24.1% are not sure while 5.9% will not recommend it. RD priority to be vaccinated against COVID-19 in descending order include SLE (82.9%), RA (55.1%), vasculitis (51.3%), systemic sclerosis (39.6%), MCTD (31.6%), Behcet's disease (28.3%). The most common drugs to be avoided before vaccination included biologics (71.7%), DMARDs (44.4%), biosimilars (26.7%), IVIg (17.1%) and NSAIDs (9.1%).

CONCLUSIONS:

The results of the study and specifically the low rate of acceptability are alarming to Egyptian health authorities and should stir further interventions to reduce the levels of vaccine hesitancy. As rheumatic disease patients in Egypt were not systematically provided with the vaccine till present, making the vaccine available could as well enhance vaccine acceptance. Further studies to investigate any possible side effects, on a large scale of RD patients are warranted.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reumatología / Actitud del Personal de Salud / Vacunación / Vacunas contra la COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Qualitative_research Límite: Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Rheumatol Int Año: 2021 Tipo del documento: Article País de afiliación: Egipto
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reumatología / Actitud del Personal de Salud / Vacunación / Vacunas contra la COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Qualitative_research Límite: Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Rheumatol Int Año: 2021 Tipo del documento: Article País de afiliación: Egipto